We are live on ! Find out more
AC

Armistice Capital Portfolio holdings

AUM $5.62B
1-Year Est. Return 36.06%
This Fund
S&P 500
This Quarter Est. Return
-27.88%
1 Year Est. Return
+36.06%
3 Year Est. Return
+44.14%
5 Year Est. Return
+38.37%
10 Year Est. Return
+188.88%
AUM
$1.32B
AUM Growth
-$346M
Cap. Flow
-$15.1M
Cap. Flow %
-1.15%
Top 10 Hldgs %
59.82%
Holding
111
New
34
Increased
24
Reduced
9
Closed
40

Top Buys

Rank Stock Value
1
CLVS
Clovis Oncology, Inc.
CLVS
+$69.5M
2
ENR icon
Energizer
ENR
+$56.7M
3
SRCL
Stericycle Inc
SRCL
+$40.3M
4
SGI
Somnigroup International
SGI
+$34.7M
5
WBT
Welbilt, Inc.
WBT
+$27.1M

Top Sells

Rank Stock Value
1
UTHR icon
United Therapeutics
UTHR
+$37.3M
2
HOG icon
Harley-Davidson
HOG
+$37.3M
3
HBI
Hanesbrands
HBI
+$36.9M
4
CPRI icon
Capri Holdings
CPRI
+$36.7M
5
CAR icon
Avis
CAR
+$32.1M

Sector Composition

Rank Sector Weight
1 Healthcare 38.78%
2 Consumer Discretionary 11.57%
3 Industrials 7.52%
4 Consumer Staples 5.7%
5 Technology 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SPY icon
1
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$778B
$375M 28.41%
1,500,000
+820,000
+121% +$221M
CLVS
2
DELISTED
Clovis Oncology, Inc.
CLVS
$90.4M 6.86%
5,036,000
+3,400,000
+208% +$69.5M
AVTX icon
3
Avalo Therapeutics
AVTX
$976M
$58.6M 4.44%
6,295
+218
+4% +$2.43M
ENR icon
4
Energizer
ENR
$1.44B
$48.2M 3.65%
+1,068,000
New +$56.7M
PLYA
5
DELISTED
Playa Hotels & Resorts
PLYA
$40.8M 3.09%
5,672,000
+2,320,000
+69% +$18.8M
EPC icon
6
Edgewell Personal Care
EPC
$1.27B
$38.1M 2.89%
1,020,000
+20,000
+2% +$873K
MNK
7
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
$36.3M 2.75%
2,300,000
+760,000
+49% +$18.9M
ENTA icon
8
Enanta Pharmaceuticals
ENTA
$372M
$35.4M 2.68%
500,000
+44,000
+10% +$3.37M
SGI
9
Somnigroup International
SGI
$15.1B
$34.1M 2.59%
3,296,000
+2,896,000
+724% +$34.7M
DFRG
10
DELISTED
Del Frisco's Restaurant Group, Inc. Common Stock
DFRG
$32.4M 2.45%
4,528,000
+772,000
+21% +$5.46M
SRCL
11
DELISTED
Stericycle Inc
SRCL
$31.5M 2.39%
+858,000
New +$40.3M
AMAG
12
DELISTED
AMAG Pharmaceuticals
AMAG
$28.5M 2.16%
1,878,000
-202,000
-10% -$3.85M
ATRS
13
DELISTED
Antares Pharma, Inc.
ATRS
$28M 2.12%
10,300,000
+1,180,000
+13% +$3.89M
VYGR icon
14
Voyager Therapeutics
VYGR
$187M
$26.7M 2.02%
2,836,000
+1,112,000
+65% +$14.3M
REGN icon
15
Regeneron Pharmaceuticals
REGN
$68.8B
$26.1M 1.98%
70,000
-5,000
-7% -$1.83M
PGNX
16
DELISTED
Progenics Pharmaceuticals Inc
PGNX
$23.9M 1.81%
5,700,000
-458,000
-7% -$2.33M
SJM icon
17
J.M. Smucker
SJM
$12.6B
$22.4M 1.7%
240,000
-276,000
-53% -$28.8M
WBT
18
DELISTED
Welbilt, Inc.
WBT
$19.5M 1.48%
+1,758,000
New +$27.1M
SJM icon
19
CALL
J.M. Smucker
SJM
$12.6B
$18.7M 1.42%
+200,000
New +$20.9M
FTDR icon
20
Frontdoor
FTDR
$5.02B
$16M 1.21%
+600,000
New +$17.8M
TJX icon
21
TJX Companies
TJX
$170B
$13.4M 1.02%
+300,000
New +$15.2M
AZO icon
22
AutoZone
AZO
$48.3B
$13.4M 1.02%
+16,000
New +$12.8M
SPPI
23
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
$13.1M 0.99%
+1,500,000
New +$19.1M
CVS icon
24
CALL
CVS Health
CVS
$137B
$13.1M 0.99%
+200,000
New +$14.9M
SBBP
25
DELISTED
Strongbridge Biopharma plc.
SBBP
$12.9M 0.98%
2,878,000
+228,000
+9% +$1.11M
1
2 3 4 5

Similar funds

CRC
Curi RMB Capital Chicago, Illinois $5.62B AUM 18.93% 1-Year Est. Return
RMDI
R.M. Davis Inc Portland, Maine $5.63B AUM 21.26% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
DWM
Diversify Wealth Management Sandy, Utah $5.61B AUM 19.63% 1-Year Est. Return
DCP
DSM Capital Partners Palm Beach Gardens, Florida $5.66B AUM 27.45% 1-Year Est. Return
EW
Evoke Wealth Los Angeles, California $5.57B AUM 23.85% 1-Year Est. Return
AIM
Alphinity Investment Management Sydney, Australia $5.68B AUM 26.72% 1-Year Est. Return
O
Ossiam Paris, France $5.69B AUM 30.95% 1-Year Est. Return

Armistice Capital's Q4 2018 Portfolio in Review

As of Q4 2018, Armistice Capital held 111 positions worth $1.32B, down 21% from $1.67B the previous quarter. Its ten largest holdings account for 60% of the portfolio.

Armistice Capital's Q4 2018 filing shows 34 new, 24 increased, 9 reduced and 40 closed positions. Its largest new stake was Energizer: 1,068,000 shares worth $48.2M. The largest sale was United Therapeutics, an estimated $37.3M.

By sector, the portfolio is most concentrated in Healthcare at 39% of assets, up from 37% a quarter earlier, followed by Consumer Discretionary and Industrials.

  • Armistice Capital's largest Q4 2018 buy was Energizer: 1,068,000 shares worth $48.2M.
  • Armistice Capital added most to Clovis Oncology, Inc. in Q4 2018, an estimated $69.5M increase.
  • Armistice Capital's biggest Q4 2018 reduction was J.M. Smucker, cutting an estimated $28.8M.
  • Armistice Capital fully exited United Therapeutics in Q4 2018, selling an estimated $37.3M.
  • Armistice Capital's ten largest holdings make up 60% of its $1.32B portfolio in Q4 2018.
  • Armistice Capital opened 34 new positions and closed 40 in Q4 2018.
  • Armistice Capital's portfolio value fell 21% quarter-over-quarter to $1.32B.

Based on Armistice Capital's 13F filing for Q4 2018, filed 14 Feb 2019.